Decode Shares Up 10 Percent as Bank Upgrades Stock | GenomeWeb
NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 10 percent, or $.35, at $3.87 after the stock was upgraded by an investment bank
Lehman Brothers upgraded the stock to "equal-weight" from "underweight."
Decode yesterday reported that fourth-quarter revenues increased 17 percent as R&D spending rose 4 percent and lossed increased 10 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.